The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five ...

The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in ...

Following a tumultuous stretch under ex-Commissioner Marty Makary, current FDA leadership is working to restore reliability, ...

The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or ...

Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two ...

Kaos Capital in a letter to other Capricor Therapeutics shareholders called for “an immediate meeting, board change, and ...

The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a ...

Melanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the ...

If Heidi Overton clears the Senate nomination process, analysts say she will have a tough job ahead to “restore ...

Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so ...

The accelerated greenlight for Ultragenyx’s gene therapy for glycogen storage disease has raised analyst expectations for ...

If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA ...